, Volume 117, Issue 3, pp 2077–2089 | Cite as

The change from an eponym to a representative name: Wegener to granulomatosis with polyangiitis

  • Saif Aldeen AlRyalatEmail author
  • Khaled Rawashdeh
  • Osama El khatib
  • Abeer Yasin
  • Fadwa Alqadi
  • Noor Saleh
  • Lna Malkawi
  • Ola Hijjawi
  • Mohammad Alessa


In 2011, professional societies recommended the use of the representative name “Granulomatosis with polyangiitis GPA” followed by the parenthetical eponym “Wegener”, due to the ethical concerns that were raised on Wegener. We aim to study the change in using the eponym “Wegener” to using the representative name “GPA” in medical literature in the period from 2010 to 2017. We used Scopus database to search for articles or reviews that used the eponym “Wegener”, and those that used the representative name “GPA” during the years 2010–2017, using appropriate operators and limiting tools available. A total of 2613 publications used the eponym “Wegener” compared to 1443 publications included the phrase “GPA” during the years 2010–2017. We found a significant difference in number of publications that used the eponym alone in the years from 2010 to 2014 (p < 0.001), reaching only 11.8% of the total publications in 2014, with no significant difference in the subsequent years (i.e. 2014–2017). USA, UK, and US-based institutions published research using the eponym alone significantly more than Germany, France, and Japan. The use of the eponym only also varied among journals. Changing an eponym to a representative name would take around 4 years to adopt the new change.


Eponym Wegener Granulomatosis with polyangiitis Scopus Bibliometrics 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. Bogdan, A., & Molina, M. J. (2017). Physical chemistry of the freezing process of atmospheric aqueous drops. The Journal of Physical Chemistry A., 121(16), 3109–3116.CrossRefGoogle Scholar
  2. Burnham, J. F. (2006). Scopus database: A review. Biomedical Digital Libraries, 3(1), 1.CrossRefGoogle Scholar
  3. CBE Style Manual Committee. (1994). Scientific style and format: The CBE manual for authors, editors, and publishers. Cambridge: Cambridge University Press.Google Scholar
  4. Coppes, M. J., & Beckwith, B. (1993). Eponyms in medicine: Possessive or nonpossessive? The Journal of Pediatrics, 122(1), 165.CrossRefGoogle Scholar
  5. DeRemee, R. A. (2010). Dr Friedrich Wegener and the American College of Chest Physicians Award. Chest, 138(3), 753.CrossRefGoogle Scholar
  6. Falk, R. J., Gross, W. L., Guillevin, L., Hoffman, G. S., Jayne, D. R., Jennette, J. C., et al. (2011). Granulomatosis with polyangiitis (Wegener’s): an alternative name for Wegener’s granulomatosis. Arthritis and Rheumatism, 63(4), 863–864.CrossRefGoogle Scholar
  7. Godman, G. C. (1954). Wegener granulomatosis. Pathology and review of the literature. Archives of Pathology, 1954(58), 533–553.Google Scholar
  8. Iverson, C. (2007). AMA manual of style: a guide for authors and editors. Chicago: American Medical Association.Google Scholar
  9. Jana, N., Barik, S., & Arora, N. (2009). Current use of medical eponyms: A need for global uniformity in scientific publications. BMC Medical Research Methodology, 9(1), 18.CrossRefGoogle Scholar
  10. Kondziella, D. (2009). Thirty neurological eponyms associated with the Nazi era. European Neurology, 62(1), 56–64.CrossRefGoogle Scholar
  11. Kondziella, D., & Zeidman, L. A. (2016). What’s in a name? Neurological eponyms of the Nazi Era. In L. Tatu & J. Bogousslavsky (Eds.), War neurology (Vol. 38, pp. 184–200). Basel: Karger Publishers.CrossRefGoogle Scholar
  12. Lefrak, S. S., & Matteson, E. L. (2007). Freidrich Wegener: The past and present. Chest, 132(6), 2065.CrossRefGoogle Scholar
  13. Lu, D. W., & Katz, K. A. (2005). Declining use of the eponym “Reiter’s syndrome” in the medical literature, 1998–2003. Journal of the American Academy of Dermatology, 53(4), 720–723.CrossRefGoogle Scholar
  14. Matteson, E. L. (2008). All medical eponyms should be abandoned. La Presse Medicale, 37(2), 250–251.CrossRefGoogle Scholar
  15. Mora, B., & Bosch, X. (2010). Medical eponyms: Time for a name change. Archives of Internal Medicine, 170(16), 1499–1500.CrossRefGoogle Scholar
  16. Rosen, M. J. (2007). Dr. Friedrich Wegener, the ACCP, and history. Chest, 132(3), 739–741.CrossRefGoogle Scholar
  17. Sargin, G., & Senturk, T. (2017). Scientific people named in the classification of vasculitis. Revista brasileira de reumatologia., 57(6), 605–609.CrossRefGoogle Scholar
  18. Strous, R. D., & Edelman, M. C. (2007). Eponyms and the Nazi era: Time to remember and time for change. IMAJ-RAMAT GAN, 9(3), 207.Google Scholar
  19. Thomas, P. B. (2016). Are medical eponyms really dying out? A study of their usage in the historical biomedical literature. The Journal of the Royal College of Physicians of Edinburgh, 46(4), 295–299.CrossRefGoogle Scholar
  20. Wegener, F. T. (1936). Uber generalisierte, septische Gefasserkrankungen. Verh dtsch pathol ges, 29, 202–209.Google Scholar
  21. Whitworth, J. A. (2007). Should eponyms be abandoned? No. BMJ, 335(7617), 425.CrossRefGoogle Scholar
  22. Woywodt, A., & Matteson, E. L. (2006). Wegener’s granulomatosis: Probing the untold past of the man behind the eponym. Rheumatology, 45(10), 1303–1306.CrossRefGoogle Scholar
  23. Woywodt, A., & Matteson, E. (2007). Head to Head: Should eponyms be abandoned? Yes. BMJ: British Medical Journal, 335(7617), 424.CrossRefGoogle Scholar

Copyright information

© Akadémiai Kiadó, Budapest, Hungary 2018

Authors and Affiliations

  1. 1.Department of OphthalmologyThe University of JordanAmmanJordan
  2. 2.Department of Internal MedicineThe University of JordanAmmanJordan
  3. 3.Department of Radiology and Nuclear MedicineThe University of JordanAmmanJordan

Personalised recommendations